Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP327743.RAisK-XprhBdALO0X3NspGeCQJ0G2Ta-dLvw4MknWc_mE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP327743.RAisK-XprhBdALO0X3NspGeCQJ0G2Ta-dLvw4MknWc_mE130_assertion type Assertion NP327743.RAisK-XprhBdALO0X3NspGeCQJ0G2Ta-dLvw4MknWc_mE130_head.
- NP327743.RAisK-XprhBdALO0X3NspGeCQJ0G2Ta-dLvw4MknWc_mE130_assertion description "[Cotreatment with BCL-2 antagonist sensitizes cutaneous T-cell lymphoma to lethal action of HDAC7-Nur77-based mechanism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP327743.RAisK-XprhBdALO0X3NspGeCQJ0G2Ta-dLvw4MknWc_mE130_provenance.
- NP327743.RAisK-XprhBdALO0X3NspGeCQJ0G2Ta-dLvw4MknWc_mE130_assertion evidence source_evidence_literature NP327743.RAisK-XprhBdALO0X3NspGeCQJ0G2Ta-dLvw4MknWc_mE130_provenance.
- NP327743.RAisK-XprhBdALO0X3NspGeCQJ0G2Ta-dLvw4MknWc_mE130_assertion SIO_000772 19074726 NP327743.RAisK-XprhBdALO0X3NspGeCQJ0G2Ta-dLvw4MknWc_mE130_provenance.
- NP327743.RAisK-XprhBdALO0X3NspGeCQJ0G2Ta-dLvw4MknWc_mE130_assertion wasDerivedFrom befree-20140225 NP327743.RAisK-XprhBdALO0X3NspGeCQJ0G2Ta-dLvw4MknWc_mE130_provenance.
- NP327743.RAisK-XprhBdALO0X3NspGeCQJ0G2Ta-dLvw4MknWc_mE130_assertion wasGeneratedBy ECO_0000203 NP327743.RAisK-XprhBdALO0X3NspGeCQJ0G2Ta-dLvw4MknWc_mE130_provenance.